Price $38.81 |
Market Cap
1.54B
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
5.3
|
P/S
6.35
|
Dividend %
-
|
|
P/CF
68.7
|
P/FCF
-
|
Op. Cash Flow
-11.5K
|
FCF
-0.4
|
|
Op. Margin
-8.30%
|
Net Margin
-8.80%
|
ROE
-8.50%
|
ROI
-9.30%
|
|
ROA
-6.50%
|
EPS Growth
-176.90%
|
Current Ratio
6.5
|
Debt/Equity
7.70%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Eyenovia Inc (EYEN) | $4.86 | - | - | 127.6M | Strong Buy |
| AmerisourceBergen Corp. (ABC) | $119.50 | - | 1.50% | 24.17B | Strong Buy |
| Bristol-Myers Squibb Co (BMY) | $65.60 | - | 3.10% | 141.03B | Strong Buy |
| ImmuCell Corporation (ICCC) | $8.50 | - | - | 69.5M | Strong Buy |
| AEterna Zentaris Inc. (USA) (AEZS) | $0.91 | - | - | 133.3M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
